Oscar Health (NYSE:OSCR) Hits New 12-Month Low – Should You Sell?

Oscar Health, Inc. (NYSE:OSCR) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $12.85 and last traded at $12.54, with a volume of 1260755 shares changing hands. The stock had previously closed at $13.76.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on OSCR. Jefferies Financial Group initiated coverage on Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective on the stock. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $21.56.

Oscar Health Price Performance

The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market cap of $3.22 billion, a price-to-earnings ratio of -644.63, a P/E/G ratio of 0.50 and a beta of 1.73. The stock has a fifty day moving average of $14.87 and a 200 day moving average of $16.80.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, analysts expect that Oscar Health, Inc. will post 0.91 EPS for the current fiscal year.

Insiders Place Their Bets

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $17.05, for a total transaction of $426,250.00. Following the transaction, the director now directly owns 89,512 shares of the company’s stock, valued at $1,526,179.60. This trade represents a 21.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Mario Schlosser sold 6,516 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $117,809.28. Following the sale, the insider now directly owns 81,962 shares of the company’s stock, valued at $1,481,872.96. This represents a 7.36 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 103,610 shares of company stock worth $1,847,519. 25.11% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Oscar Health

Hedge funds and other institutional investors have recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC raised its stake in Oscar Health by 7.5% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock valued at $255,000 after purchasing an additional 844 shares during the last quarter. KBC Group NV grew its holdings in shares of Oscar Health by 41.2% during the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock worth $97,000 after buying an additional 1,328 shares in the last quarter. Arizona State Retirement System grew its holdings in shares of Oscar Health by 3.1% during the fourth quarter. Arizona State Retirement System now owns 47,918 shares of the company’s stock worth $644,000 after buying an additional 1,454 shares in the last quarter. Xponance Inc. raised its position in shares of Oscar Health by 12.9% in the fourth quarter. Xponance Inc. now owns 14,394 shares of the company’s stock valued at $193,000 after buying an additional 1,649 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its stake in shares of Oscar Health by 1.7% in the third quarter. Allspring Global Investments Holdings LLC now owns 109,074 shares of the company’s stock worth $2,313,000 after buying an additional 1,866 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.